Almaarefa University
The authoritative source for research information and outputs is Elsevier Scopus, with researcher profile verification from the Deanship of Scientific Research.

المخرجات

Research outputs

Articles, reviews, conference papers and book chapters, indexed by DOI and linked to University researchers.

2 output Results for «Vitiligo»

ArticleOpen access2026

Stigmatization in patients with chronic skin diseases in the Eastern Region of Saudi Arabia: a cross-sectional study

Dermatology Reports

Chronic skin diseases such as psoriasis, vitiligo, eczema, and acne can have substantial psychosocial effects beyond physical symptoms. Visible dermatological conditions often lead to stigmatization, which may negatively influence social interactions, emotional well-being, and quality of life. However, limited research has examined perceived stigmatization among patients with chronic skin diseases in the Eastern Province of Saudi Arabia. This study aimed to quantify and compare perceived stigmatization among patients with chronic skin diseases and identify demographic and clinical factors associated with stigma severity. A cross-sectional study was conducted among 446 patients with chronic skin diseases. Data were collected using a structured questionnaire, including sociodemographic characteristics, clinical information, and the 6-Item Stigmatization Scale. Descriptive statistics were used to summarize participant characteristics. Independent t-tests, one-way analysis of variance (ANOVA), and multivariable linear regression analysis were performed to examine associations between stigma scores and demographic and clinical variables. A total of 446 participants were included, with females comprising 264 (59.2%) and most aged 18-40 years (291, 65.2%). Vitiligo (114, 25.6%) and psoriasis (102, 22.9%) were the most common conditions. Many participants reported stigma-related experiences, including feeling unattractive sometimes or very often (326, 73.0%). Stigma scores were significantly higher among males than females (8.12±3.93 vs. 7.03±4.73, p=0.011) and varied by monthly income (p<0.001). Stigma also differed across disease types (p<0.001), with the highest scores among vitiligo patients (8.74±3.98). In regression analysis, gender (B=1.039, p=0.016), age at disease onset (B=0.052, p=0.002), disease duration (B=-1.268, p=0.003), and family history (B=1.825, p<0.001) were significant predictors of stigma. To conclude, stigmatization is a common psychosocial burden among patients with chronic skin diseases. Addressing stigma through patient support, public education, and integrated psychological care may help improve the well-being of affected individuals.

chronic skin diseasepsoriasisvitiligoatopic dermatitis
ArticleOpen access2026

Vitiligo like depigmentation in a patient with NHEJ1 deficiency related radiosensitive SCID: A case report

JAAD Case Reports · vol. 73 · 106-110

Severe combined immunodeficiency (SCID) represents a group of life-threatening primary immunodeficiencies characterized by defective T and B-lymphocyte function, typically presenting with severe and recurrent infections during early infancy.1 A subgroup of them, referred to as radiosensitive SCID, results from defects within the nonhomologous end-joining (NHEJ) pathway, which plays a crucial role in DNA double-strand break repair during V(D)J recombination. The NHEJ1 gene encodes for Cernunnos/XLF, an NHEJ1 scaffolding protein that is vital for DNA end ligation during this form of repair.

vitiligo-like depigmentationsevere combined immunodeficiencynon-homologous end joiningDNA double-strand break repair